Icon Group participates in a wide variety of clinical trials and research projects ranging from global, multi-centre, commercially-sponsored clinical trials of experimental agents, to studies developed by Icon staff, doctors and visiting medical officers (VMOs) to better understand, treat, or alleviate the diagnosis, symptoms or concerns of patients with cancer and blood disorders.
Research at Icon Group facilitates:
- Direct access to clinical trials for patients as close to home as possible
- Trial management and delivery with Australia’s largest private provider of cancer clinical trials
- Coverage across Australia, New Zealand, Singapore and Hong Kong cancer centres
- Specialised facilities with cutting-edge technologies
- Passionate clinicians and a commitment to an innovative research-oriented environment